Personal information

Websites & social links

University of Birmingham Staff Profile

Other IDs

Scopus Author ID: 7005254685

Keywords

cancer, oncology, colorectal, NSLC

Countries

United Kingdom

Activities

Collapse all

Employment (1)

University of Birmingham: Birmingham, West Midlands, GB

Professor of Medical Oncology (Institute of Immunology and Immunotherapy)
Employment
Source: Self-asserted source
Gary Middleton

Funding (4)

KETO-Lung: assessing the impact of the adoption of a continuous ketogenic diet on the efficacy of combination chemo-immunotherapy using paclitaxel/carboplatin/pembrolizumab in advanced squamous cell cancer of the lung

2023-06-01 to 2026-05-31 | Grant
Cancer Research UK (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.13913433
GRANT_NUMBER: CRCEMA-Nov22/100002
Source: Self-asserted source
Gary Middleton via DimensionsWizard

Birmingham ECMC

2023-04-01 to 2028-03-31 | Grant
Cancer Research UK (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.13913431
GRANT_NUMBER: ECMCQQR-2022/100007
Source: Self-asserted source
Gary Middleton via DimensionsWizard

The Birmingham CRUK Centre Clinical Academic Training and Research Programme

2019-10-01 to 2024-12-31 | Grant
Cancer Research UK (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.13913437
GRANT_NUMBER: 28789
Source: Self-asserted source
Gary Middleton via DimensionsWizard

CRUK/13/072 LungMatrix: Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer

2016-10-01 to 2025-04-30 | Grant
Cancer Research UK (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.7751016
GRANT_NUMBER: 22209
Source: Self-asserted source
Gary Middleton via DimensionsWizard

Peer review (1 review for 1 publication/grant)

Review activity for Nature communications (1)
How many people are using ORCID?